Jinglin Xia

机构：Fudan University, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Zhongshan Hospital · ORCID：0000-0001-9443-7075

发表论文 149 篇 · 总被引 3959 次 · h-index 35

代表论文

• Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC (2024 · Oncogene · 被引 18)
• Stimuli-responsive hydrogel microspheres encapsulated with tumor-cell-derived microparticles for malignant ascites treatment (2024 · Acta Biomaterialia · 被引 17)
• Targeting JMJD6/PPARγ/GPX4 axis overcomes ferroptosis resistance and enhances therapeutic efficacy in hepatocellular carcinoma (2025 · Oncogene · 被引 16)
• Emulsifying Lipiodol with pH-sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis (2023 · Materials Today Bio · 被引 14)
• Mi-BMSCs alleviate inflammation and fibrosis in CCl4-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signaling (2024 · Materials Today Bio · 被引 11)
• Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score (2024 · BMC Cancer · 被引 10)